In order to address the rapidly evolving landscape of SARS-CoV-2 (COVID-19) testing, we wanted to take a moment to share important information and updates with DTPM clients. We appreciate the opportunity to serve and work alongside each of you who are committed to meeting the demand in our public health emergency. We know that many of you assist diverse communities throughout our country and have encountered substantial challenges over the past 18 months. While our nation continues to improve the distribution and compliance with vaccines, we understand that the fight against COVID-19 is not over.

Over the past year, Americans and those across our world, have encountered new and emerging strains or “variants” of the coronavirus. These mutations have created many challenges for healthcare professionals to detect and treat COVID-19 within their communities. Manufacturers of testing supplies must regularly evaluate the publicly available information to ascertain how these variants impact product efficacy. As such, we wanted to provide each of our you with information which will help to address questions from those whom you serve as well. After careful analysis of the genetic sequence information made available from collaborations of scientists across the world, we have determined through in silico analysis, that the DTPM COVID-19 RT-PCR test would detect the following SARS-CoV-2 Variants in addition to the original strain.

B.1.1.7 (alpha); B.1.351 (beta); P.1 (gamma); B.1.617.2 (delta); B.1.617.1 (kappa); B.1.427, B.1.429 (epsilon); B.1.525 (eta); B.1.526 (lota); C.37 (lambda); B.1.177; B.1.621; B.1.1.519; B.1.620; B.1.160; B.1.258; B.1.221; B.1.367; B.1.1.277; B.1.1.302

We will continue to monitor the emerging evidence and evaluate how new variants may impact the efficacy of testing strategies. We will provide additional updates as they become available. We appreciate all of the feedback received from your experiences and want to encourage your laboratory to reach out if you have any questions or if we may be of assistance. Thank you to all of our laboratory professionals who serve tirelessly to do our part in combating the spread of COVID-19.

Best Regards,

W. Justin Lawson, MS, MBA
Director of Laboratory Operations